Every Thursday we send out a curated newsletter on “all things femtech”. This is the latest edition. If you’re interested in subscribing, you can do so at the bottom of this page.
The FDA authorized Everlywell COVID-19 Test Home Collection Kit will be available for individual purchase by the end of the month.
Highlights
At-home hormone testing company Everlywell gains first FDA approval for a standalone COVID-19 test kit; Applications for Bayer’s G4A accelerator are now open and startups working on women’s health challenges are encouraged to apply; Omada Health, which provides digital tools for people with chronic health conditions raises $57M and spends $30M million of it acquiring Physera; Applications are open for Springboard Enterprises’s Dolphin Tank, an event, that offers healthtech entrepreneurs insights and resources; I Ally, an app for millennial caregivers is currently raising $5K on IFundWomen; Kliit Health is organizing a free femtech conference on May 23; Nature releases a new analysis of Rock Health’s database of digital health startups
You’ve found some of our exclusive Inner Circle Content.
This article is only available for our Inner Circle Members. To read on:
Kathrin Folkendt is the Founder & CEO of Femtech Insider, the globally leading publication on all things femtech. She usually writes about women's health innovation, health equity, and entrepreneurship.
